We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
+14.24%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.19B
AUM Growth
-$189M
(-7.9%)
Cap. Flow
-$471M
Cap. Flow
% of AUM
-21.5%
Top 10 Holdings %
Top 10 Hldgs %
25.76%
Holding
204
New
59
Increased
25
Reduced
88
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SolarEdge
SEDG
|
+$41.5M |
| 2 |
Illumina
ILMN
|
+$40.9M |
| 3 |
QuidelOrtho
QDEL
|
+$34.1M |
| 4 |
CIVI
Civitas Resources
CIVI
|
+$18.5M |
| 5 |
FMC
FMC
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$245M |
| 2 |
Apple
AAPL
|
+$85.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$56.2M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$40.7M |
| 5 |
Corpay
CPAY
|
+$40.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.91% |
| 2 | Consumer Discretionary | 12.94% |
| 3 | Healthcare | 12.41% |
| 4 | Communication Services | 8.9% |
| 5 | Industrials | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGD
51
DELISTED
New Gold Inc
NGD
| $14.7M | 0.67% |
10,101,164
+1,654,396
| +20% | +$2.08M |
|
52
Ameren
AEE
$29.7B
| $14.7M | 0.67% |
203,734
-184,952
| -48% | -$14.1M |
|
53
Liberty Broadband Class C
LBRDK
$5.14B
| $14.6M | 0.67% |
+181,653
| New | +$15.2M |
|
|
VRN
54
DELISTED
Veren
VRN
| $14.1M | 0.64% |
2,029,368
-980,912
| -33% | -$7.24M |
|
|
NVEI
55
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $14M | 0.64% |
531,722
-649,430
| -55% | -$12.5M |
|
56
Sprouts Farmers Market
SFM
$8.03B
| $13.8M | 0.63% |
+287,681
| New | +$12.6M |
|
57
Levi Strauss
LEVI
$9.26B
| $13.4M | 0.61% |
807,495
-595,334
| -42% | -$8.83M |
|
|
K
58
DELISTED
Kellanova
K
| $13.2M | 0.6% |
+235,901
| New | +$12.3M |
|
59
Pediatrix Medical
MD
$2.12B
| $12.8M | 0.58% |
1,377,951
+664,955
| +93% | +$6.88M |
|
60
Copa Holdings
CPA
$5.61B
| $12.4M | 0.57% |
116,800
+55,492
| +91% | +$5.07M |
|
61
Sanmina
SANM
$11B
| $12.2M | 0.56% |
+236,984
| New | +$12.1M |
|
62
CVS Health
CVS
$122B
| $12.2M | 0.55% |
154,047
-111,529
| -42% | -$7.94M |
|
63
TripAdvisor
TRIP
$1.24B
| $12.1M | 0.55% |
563,560
-405,250
| -42% | -$7.11M |
|
64
Generac Holdings
GNRC
$12.4B
| $12.1M | 0.55% |
+93,752
| New | +$10.3M |
|
65
Kohl's
KSS
$2.19B
| $12M | 0.55% |
+416,749
| New | +$9.77M |
|
66
Shell
SHEL
$249B
| $11.4M | 0.52% |
172,892
-71,870
| -29% | -$4.72M |
|
67
Eastman Chemical
EMN
$8.38B
| $11.3M | 0.52% |
126,267
-27,175
| -18% | -$2.17M |
|
|
B
68
Barrick Mining
B
$68.1B
| $11.3M | 0.52% |
+624,962
| New | +$10.3M |
|
69
Conagra Brands
CAG
$7.11B
| $10.4M | 0.47% |
+361,487
| New | +$10.1M |
|
70
American Vanguard Corp
AVD
$68.1M
| $9.62M | 0.44% |
876,708
+631,070
| +257% | +$6.29M |
|
71
Envista
NVST
$4.5B
| $9.27M | 0.42% |
+385,468
| New | +$9.21M |
|
72
Fiverr
FVRR
$323M
| $9.15M | 0.42% |
+336,096
| New | +$8.32M |
|
|
DMC
73
Del Monte Corp
DMC
$1.42B
| $9.06M | 0.41% |
344,975
+78,067
| +29% | +$1.92M |
|
|
HSII
74
DELISTED
Heidrick & Struggles
HSII
| $8.76M | 0.4% |
296,550
-91,960
| -24% | -$2.44M |
|
75
Fidelity National Information Services
FIS
$21.9B
| $8.74M | 0.4% |
145,514
-25,388
| -15% | -$1.39M |
|
Similar funds
SIG
CAG
ORCP
ET
GC
MIAS
TAL
IIP
Invenomic Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Invenomic Capital Management held 204 positions worth $2.19B, down 7.9% from $2.38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Invenomic Capital Management withdrew a net $471M in Q4 2023, closing 32 positions and reducing 88 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $245M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Invenomic Capital Management opened a new position in SolarEdge worth $42.6M.
- Invenomic Capital Management's largest Q4 2023 buy was SolarEdge: 455,600 shares worth $42.6M.
- Invenomic Capital Management added most to IPG Photonics in Q4 2023, an estimated $11.6M increase.
- Invenomic Capital Management's biggest Q4 2023 reduction was Corpay, cutting an estimated $40.2M.
- Invenomic Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2023, selling an estimated $245M.
- Invenomic Capital Management's ten largest holdings make up 26% of its $2.19B portfolio in Q4 2023.
- Invenomic Capital Management opened 59 new positions and closed 32 in Q4 2023.
- Invenomic Capital Management's portfolio value fell 7.9% quarter-over-quarter to $2.19B.
Based on Invenomic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.